PATENT CLAIM ANALYSIS

Application Number: 16319808
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["424", "001890"]

Abstract:
The present invention relates to novel compounds of the formula (I) that can be employed in the selective Tau detection of disorders and abnormalities associated with Tau aggregates such as Alzheimer's disease and other tauopathies using Positron Emission Tomography (PET) Imaging.

Claim (Index 30):
A method of determining the amount of tau aggregate in a tissue and/or a body fluid comprising:\n (a) providing a sample representative of the tissue and/or body fluid under investigation; (b) testing the sample for the presence of tau aggregate with a compound as defined in  claim 11 ; (c) determining the amount of compound bound to the tau aggregate; and (d) calculating the amount of tau aggregate in the tissue and/or body fluid.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 99.0
- Lexical Diversity: 1.14634
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15112672', '14740595', '14486040', '15324141', '15750982']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7182973840048706
- 35 USC 102 Novelty (BERT): 0.5511450882612711
- Combined Prediction Score: 0.7015821544305108
- Mean Citation Score: 325.844132
- Max Citation Score: 440.98587
- Similarity Product: 298.47832513660313

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test